European Commission logo
English English
CORDIS - EU research results
CORDIS

Development of a Chimpanzee Adenovirus Type 3 Ebolavirus Zaire Vaccine

Deliverables

Web based platform live

the web-based management platform will be built and operational within the first 6 months of the project (GSK). Then, the content will be regularly updated.

Publications

Safety and immunogenicity of a chimpanzee adenovirus-vectored Ebola vaccine in healthy adults: a randomised, double-blind, placebo-controlled, dose-finding, phase 1/2a study

Author(s): Olga De Santis, Régine Audran, Emilie Pothin, Loane Warpelin-Decrausaz, Laure Vallotton, Grégoire Wuerzner, Camille Cochet, Daniel Estoppey, Viviane Steiner-Monard, Sophie Lonchampt, Anne-Christine Thierry, Carole Mayor, Robert T Bailer, Olivier Tshiani Mbaya, Yan Zhou, Aurélie Ploquin, Nancy J Sullivan, Barney S Graham, François Roman, Iris De Ryck, W Ripley Ballou, Marie Paule Kieny, Vasee M
Published in: The Lancet Infectious Diseases, Issue 16/3, 2016, Page(s) 311-320, ISSN 1473-3099
Publisher: The Lancet Publishing Group
DOI: 10.1016/S1473-3099(15)00486-7

A review of Phase I trials of Ebola virus vaccines: what can we learn from the race to develop novel vaccines?

Author(s): Teresa Lambe, Georgina Bowyer, Katie J Ewer
Published in: Philosophical Transactions of the Royal Society B: Biological Sciences, Issue 372/1721, 2017, Page(s) 20160295, ISSN 0962-8436
Publisher: Royal Society of London
DOI: 10.1098/rstb.2016.0295

Searching for OpenAIRE data...

There was an error trying to search data from OpenAIRE

No results available